Our recruiters have collectively hired thousands and know all the ins and outs of the process—and they love sharing their knowledge.
This content isn’t available here
Access this content and more in the LinkedIn app
At Johnson & Johnson, we believe health is everything. As a focused healthcare company, with expertise in Innovative Medicine and MedTech, we’re empowered to tackle the world’s toughest health challenges, innovate through science and technology, and transform patient care. All of this is possible because of our people. We’re passionate innovators who put people first, and through our purpose-driven culture and talented workforce, we are stronger than ever. Learn more at https://www.jnj.com. Community Guidelines: http://www.jnj.com/social-media-community-guidelines
External link for Johnson & Johnson
Prostate cancer remains the second-leading cause of cancer death among American men, but physician scientist Victor aims to change that—and you can join him on our #oncology team right now. Learn more: https://bit.ly/3UVe5lb
What does it take to find a cure for multiple myeloma? Meet one of our scientists at the forefront of our work to develop innovative blood cancer treatments and see what drives him: https://lnkd.in/eeFNepHZ
At Johnson & Johnson, we aim to increase health equity through programs like Sight for Kids—our global eye care partnership helping restore vision to families across the world: https://lnkd.in/ev-DBTND
We’re headed to Barcelona, Spain for ESMO - European Society for Medical Oncology 2024 Conference on September 13th - September 17th and you’re invited to be part of it! Meet us at booth 610 and connect with our oncology, medical affairs, market access and R&D leaders and recruiting team, to learn how your skills can solve the world’s toughest health challenges at Johnson & Johnson. Register to our talent hub here https://lnkd.in/dYNANrgU Eline De Nys, Ícaro Taynan (him/his), Gert Quintiens, Iva Yanakieva, Amanda Waldowski, Miles D. Freeman, Dan Kollock CDR, CIR, Matt Houseman #ESMO24 #oncology
This content isn’t available here
Access this content and more in the LinkedIn app
Innovating to bridge gaps between biology and technology means “reimagining the meaning of a cancer diagnosis,” according to Maren, Senior Global Compound Market Access Lead. Learn how you can join her on our #MarketAccess team today: https://bit.ly/3WAvdh3
Carlos is one of the 6.7 million adults in the U.S. with heart failure. After being admitted to the emergency room for troubling heart symptoms, Carlos soon learned that the coronary artery disease he’d been diagnosed with years earlier had progressed to congestive heart failure. We're committed to advancing treatments for heart failure so patients like Carlos can lead full, active lives. Read about Carlos’s journey and the strides we are making: https://lnkd.in/eEaKVgFE
We’re closing the gap between communities and care by increasing access to our medicines and technologies, championing healthcare workers and partnering with community-based organizations: https://lnkd.in/eZ2QW4x7
Use your career to take on some of the most complex diseases of our time. Learn why Katie, Ph.D, Senior Director, Patient Reported Outcomes, says, “Every day we’re getting one step closer to curing cancer”—and find out how you can join her on our #oncology team: https://bit.ly/3UCxV3e
We use our size, scale, and diversity to change lives and communities, advancing equitable care and putting better health within reach. Explore how: https://lnkd.in/eEMmmZy8
JNJ
NYSE
20 minutes delay
$160.62
0.4 (0.25%)
Data from Refinitiv
See more info on